(Q42824172)

8 November 2017

Spontaneous loss of heterozygosity leading to homozygous R132H in a patient-derived IDH1 mutant cell line (English)

1 reference

8 November 2017

0 references

1 reference

1 reference

3

J Gregory Cairncross

1 reference

8 November 2017

H Artee Luchman

1

1 reference

8 November 2017

Charles Chesnelong

series ordinal

2

1 reference

8 November 2017

Samuel Weiss

series ordinal

4

1 reference

8 November 2017

11 June 2013

1 reference

8 November 2017

1 reference

8 November 2017

15

1 reference

8 November 2017

8

1 reference

8 November 2017

979-980

1 reference

describes a project that uses

8 November 2017

BT142 mut/-

0 references

cites work

The potential for isocitrate dehydrogenase mutations to produce 2-hydroxyglutarate depends on allele specificity and subcellular compartmentalization.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3714156

PubMed Central

reference URL

Disruption of wild-type IDH1 suppresses D-2-hydroxyglutarate production in IDH1-mutated gliomas.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3714156

PubMed Central

reference URL

An in vivo patient-derived model of endogenous IDH1-mutant glioma

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3714156

PubMed Central

reference URL

27 May 2018

Identifiers

DOI

10.1093/NEUONC/NOT064

1 reference

8 November 2017

1 reference

8 November 2017

PubMed publication ID

23757293

1 reference